Načítá se...
Association of coagulopathy with liver dysfunction in patients with COVID‐19
AIM: Liver dysfunction is sometimes observed in patients with coronavirus disease 2019 (COVID‐19), but most studies are from China, and the frequency in other countries is unclear. In addition, previous studies suggested several mechanisms of liver damage, but precise or additional mechanisms are no...
Uloženo v:
| Vydáno v: | Hepatol Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675264/ https://ncbi.nlm.nih.gov/pubmed/33047431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hepr.13577 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|